The anti-tumor efficiency of low-dose apatinib-based chemotherapy in pretreated HER2-negative breast cancer with brain metastases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The anti-tumor efficiency of low-dose apatinib-based chemotherapy in pretreated HER2-negative breast cancer with brain metastases

Published:2023-06 Issue:1 Volume:55 Page:
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Chen Xuelian¹,Bai Xue¹,Xie Xiaofeng¹,Huang Jiayi¹,Chen Liping¹,Song Lin¹,Lan Xiaofeng¹,Zhang Qiuyi¹,Guo Jinfeng¹,Du Caiwen¹

Affiliation:

1. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, P.R. China

Funder

ShenZhen basic research program

National Natural Science Foundation of China

National Natural Science Foundation of Guangdong province

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2023.2218647

Reference32 articles.

1. Optimal Management of Brain Metastases from Breast Cancer

2. CNS Metastases in Breast Cancer

3. Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort

4. The Biology of Brain Metastasis

5. The blood-brain barrier: Bottleneck in brain drug development

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP